FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip McGlave

Research Profile

Procedures

Disorders

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
P Ramirez; Michael verneris; John E Wagner; Daniel J Weisdorf; Todd E DeFor; Philip B McGlave; David H McKenna; Jeffrey S Miller; Bruce R Blazar; Claudio G Brunstein
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd E DeFor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
J R Long-Boyle; K G Green; Claudio G Brunstein; Q Cao; John Rogosheske; Daniel J Weisdorf; Jeffrey S Miller; John E Wagner; Philip B McGlave; Pamala A Jacobson
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip McGlave (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: P Ramirez; Michael verneris; John E Wagner; Daniel J Weisdorf; Todd E DeFor; Philip B McGlave; David H McKenna; Jeffrey S Miller; Bruce R Blazar; Claudio G Brunstein
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(6):799-803.
2011: Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd E DeFor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Blood 2011;117(3):1061-70.
2011: J R Long-Boyle; K G Green; Claudio G Brunstein; Q Cao; John Rogosheske; Daniel J Weisdorf; Jeffrey S Miller; John E Wagner; Philip B McGlave; Pamala A Jacobson
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.
Bone marrow transplantation 2011;46(1):20-6.
2009: Michael verneris; Claudio G Brunstein; Juliet N Barker; Margaret L MacMillan; Todd E DeFor; David H McKenna; Michael J Burke; Bruce R Blazar; Jeffrey S Miller; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
Blood 2009;114(19):4293-9.
2009: Michael B Tomblyn; Mukta Arora; K Scott Baker; Bruce R Blazar; Claudio G Brunstein; Linda J Burns; Todd E DeFor; Kathryn E Dusenbery; Dan S Kaufman; John H Kersey; Margaret L MacMillan; Philip B McGlave; Jeffrey S Miller; Paul J Orchard; Arne Slungaard; Marcie R Tomblyn; Gregory M Vercellotti; Michael verneris; John E Wagner; Daniel J Weisdorf
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3634-41.
2009: Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; D McKenna; S Y Chong; Jeffrey S Miller; Philip B McGlave; John E Wagner
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.
Bone marrow transplantation 2009;43(12):935-40.
2009: Claudio G Brunstein; Susana Cantero; Qing Cao; Navneet S Majhail; Brian McClune; Linda J Burns; Marcie Tomblyn; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):214-22.
2008: Navneet S Majhail; Claudio G Brunstein; Marcie Tomblyn; Avis J Thomas; Jeffrey S Miller; Mukta Arora; Dan S Kaufman; Linda J Burns; Arne Slungaard; Philip B McGlave; John E Wagner; Daniel J Weisdorf
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(3):282-9.
2007: Smita Bhatia; Liton Francisco; Andrea Carter; Canlan Sun; K Scott Baker; James G Gurney; Philip B McGlave; Auayporn Nademanee; Margaret O'Donnell; Norma K C Ramsay; Leslie L Robison; David Snyder; Anthony Stein; Stephen J Forman; Daniel J Weisdorf
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
Blood 2007;110(10):3784-92.
2007: Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; John E Wagner
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.
Blood 2007;110(8):3064-70.
2007: M Tomblyn; Linda J Burns; Bruce R Blazar; J Wagner; C Lee; T Rogers; Philip B McGlave; Jeffrey S Miller; Daniel J Weisdorf
Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
Bone marrow transplantation 2007;40(2):111-8.
2007: David H McKenna; Darin Sumstad; Nancy Bostrom; Diane Kadidlo; Susan Fautsch; Sarah McNearney; Rose Dewaard; Philip B McGlave; Daniel J Weisdorf; John E Wagner; Jeffrey McCullough; Jeffrey S Miller
Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.
Transfusion 2007;47(3):520-8.
2007: Pamala Jacobson; Kathleen Green; John Rogosheske; Claudio G Brunstein; Breta Ebeling; Todd E DeFor; Philip B McGlave; Daniel Weisdorf
Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
Journal of clinical pharmacology 2007;47(1):6-12.
2006: Navneet S Majhail; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Philip B McGlave; Arne Slungaard; Mukta Arora; Norma K C Ramsay; Paul J Orchard; Margaret L MacMillan; Linda J Burns
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1065-72.
2006: Noel Laudi; Mukta Arora; Linda J Burns; Philip B McGlave; Jeffrey Miller; Gerald Bohac; Tyson Rogers; Juliet N Barker; James E Coad; Daniel Weisdorf
Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma.
American journal of hematology 2006;81(7):519-24.
2006: Andrea Carter; Leslie L Robison; Liton Francisco; David Smith; Marcia Grant; K Scott Baker; James G Gurney; Philip B McGlave; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Bone marrow transplantation 2006;37(11):1023-9.
2005: Pamala Jacobson; John Rogosheske; Juliet N Barker; Kathleen Green; Juki Ng; Daniel Weisdorf; Ye Tan; Janel Long; Rory P Remmel; Ronald Sawchuk; Philip B McGlave
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.
Clinical pharmacology and therapeutics 2005;78(5):486-500.
2005: M Arora; Philip B McGlave; Linda J Burns; Jeffrey S Miller; J N Barke; Todd E DeFor; Daniel J Weisdorf
Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma.
Bone marrow transplantation 2005;35(12):1133-40.
2005: Smita Bhatia; Leslie L Robison; Liton Francisco; Andrea Carter; Yan Liu; Marcia Grant; K Scott Baker; Henry Fung; James G Gurney; Philip B McGlave; Auayporn Nademanee; Norma K C Ramsay; Anthony Stein; Daniel J Weisdorf; Stephen J Forman
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Blood 2005;105(11):4215-22.
2005: Jeffrey S Miller; Yvette Soignier; Angela Panoskaltsis-Mortari; Sarah A McNearney; Gong H Yun; Susan K Fautsch; David McKenna; Chap Le; Todd E DeFor; Linda J Burns; Paul J Orchard; Bruce R Blazar; John E Wagner; Arne Slungaard; Daniel J Weisdorf; Ian J Okazaki; Philip B McGlave
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Blood 2005;105(8):3051-7.
2005: Noel Laudi; Mukta Arora; Linda J Burns; Jeffrey S Miller; Philip B McGlave; Juliet N Barker; Norma K C Ramsay; Paul J Orchard; Margaret L MacMillan; Daniel J Weisdorf
Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):129-35.
2005: Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Philip B McGlave; Jeffrey S Miller; Catherine M Verfaillie; John E Wagner
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.
Blood 2005;105(3):1343-7.
2005: Philip B McGlave
Allogeneic transplantation for chronic myelogenous leukemia.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():15-8.
2004: K Scott Baker; James G Gurney; Kirsten K Ness; Ravi Bhatia; Stephen J Forman; Liton Francisco; Philip B McGlave; Leslie L Robison; David S Snyder; Daniel J Weisdorf; Smita Bhatia
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study.
Blood 2004;104(6):1898-906.
2004: Ravi Bhatia; Philip B McGlave
Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.
Hematology/oncology clinics of North America 2004;18(3):715-32, xi.
2004: Elena G Chiorean; Todd E DeFor; Daniel J Weisdorf; Bruce R Blazar; Philip B McGlave; Linda J Burns; Charlotte Brown; Jeffrey S Miller
Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):171-7.
2003: Daniel Anderson; Todd E DeFor; Linda J Burns; Philip B McGlave; Jeffrey Miller; John Wagner; Daniel Weisdorf
A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(1):52-9.
2002: Juliet N Barker; Stella M Davies; Todd E DeFor; Linda J Burns; Philip B McGlave; Jeffrey S Miller; Daniel J Weisdorf
Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults.
British journal of haematology 2002;118(1):101-7.
2002: Daniel J Weisdorf; Claudio Anasetti; Joseph H Antin; Nancy A Kernan; Craig Kollman; David Snyder; Effie W Petersdorf; Gene Nelson; Philip B McGlave
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Blood 2002;99(6):1971-7.
2001: Effie W Petersdorf; Craig Kollman; Carolyn Katovich Hurley; Bo Dupont; Auayporn Nademanee; Ann B Begovich; Daniel Weisdorf; Philip B McGlave
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Blood 2001;98(10):2922-9.
2001: S M Davies; Todd E DeFor; Philip B McGlave; J S Miller; C M Verfaillie; John E Wagner; Daniel J Weisdorf
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
The American journal of medicine 2001;110(5):339-46.
2001: Claudio G Brunstein; Philip B McGlave
The biology and treatment of chronic myelogenous leukemia.
Oncology (Williston Park, N.Y.) 2001;15(1):23-31; discussion 31-2, 35.
2000: Claudio G Brunstein; B A Hirsch; Jeffrey S Miller; Ronald C McGlennen; Catherine M Verfaillie; Philip B McGlave; Daniel J Weisdorf
Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse.
Bone marrow transplantation 2000;26(11):1173-7.
2000: Paul V Browne; Daniel J Weisdorf; Todd E DeFor; Wesley J Miller; Stella M Davies; Alexandra H Filipovich; Philip B McGlave; Norma K C Ramsay; J Wagner; Helen Enright
Response to thalidomide therapy in refractory chronic graft-versus-host disease.
Bone marrow transplantation 2000;26(8):865-9.
2000: J D Lickliter; Philip B McGlave; Todd E DeFor; Jeffrey S Miller; Norma K C Ramsay; C M Verfaillie; Linda J Burns; John E Wagner; Ted Eastlund; Kathryn E Dusenbery; Daniel J Weisdorf
Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
Bone marrow transplantation 2000;26(7):723-8.
2000: Philip B McGlave
Hematopoietic stem-cell transplantation from an unrelated donor.
Hospital practice (1995) 2000;35(8):43-6, 49-52, 55; discussion 55-6.
2000: Philip B McGlave; X O Shu; W Wen; C Anasetti; Auayporn Nademanee; R Champlin; Joseph H Antin; Nancy A Kernan; R King; D J Weisdorf
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.
Blood 2000;95(7):2219-25.
2000: Sergio Giralt; R Szydlo; John M Goldman; J Veum-Stone; J C Biggs; Roger H Herzig; John P Klein; Philip B McGlave; Gary Schiller; Robert Peter Gale; Philip Rowlings; Mary M Horowitz
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
Blood 2000;95(2):410-5.
2000: Louise Cragg; B R Blazar; Todd E DeFor; N Kolatker; Wesley J Miller; John H Kersey; M Ramsay; Philip B McGlave; Alexandra H Filipovich; Daniel Weisdorf
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4A):441-7.
1999: Thomas G Gross; Michael Steinbuch; Todd E DeFor; R S Shapiro; Philip B McGlave; Norma K C Ramsay; John E Wagner; Alexandra H Filipovich
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.
Bone marrow transplantation 1999;23(3):251-8.
1998: Catherine M Verfaillie; R Bhatia; Michael Steinbuch; Todd E DeFor; Betsy Hirsch; Jeffrey S Miller; Daniel Weisdorf; Philip B McGlave
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.
Blood 1998;92(5):1820-31.
1998: H Enright; Philip B McGlave
Bone marrow transplantation for chronic myelogenous leukemia.
Current opinion in oncology 1998;10(2):100-7.
1998: Robert Peter Gale; R Hehlmann; Mei-Jie Zhang; Joerg Hasford; John M Goldman; Hermann Heimpel; A Hochhaus; John P Klein; Hans-Jochem Kolb; Philip B McGlave; Jakob R Passweg; Philip Rowlings; Kathleen A Sobocinski; Mary M Horowitz
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.
Blood 1998;91(5):1810-9.
1998: Philip B McGlave
Unrelated donor transplant therapy for chronic myelogenous leukemia.
Hematology/oncology clinics of North America 1998;12(1):93-105.
1997: Sandra Lee; Karen M Kuntz; Mary M Horowitz; Philip B McGlave; J M Goldman; Kathleen A Sobocinski; Janet Hegland; Craig Kollman; Susan K Parsons; Milton C Weinstein; Jane C Weeks; Joseph H Antin
Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.
Annals of internal medicine 1997;127(12):1080-8.
1997: Daniel Weisdorf; Jeffrey Miller; Catherine M Verfaillie; Linda J Burns; J Wagner; Bruce R Blazar; S Davies; Wesley J Miller; P Hannan; Michael Steinbuch; Norma K C Ramsay; Philip B McGlave
Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):217-23.
1997: Mei-Jie Zhang; M Baccarani; Robert Peter Gale; Philip B McGlave; KA Atkinson; Richard E Champlin; K A Dicke; Sergio Giralt; Eliane Gluckman; John M Goldman; John P Klein; Roger H Herzig; T Masaoka; Richard J O'Reilly; C Rozman; Philip Rowlings; Kathleen A Sobocinski; B Speck; F E Zwaan; Mary M Horowitz
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.
British journal of haematology 1997;99(1):23-9.
1997: Helen Enright; Philip B McGlave
Biology and treatment of chronic myelogenous leukemia.
Oncology (Williston Park, N.Y.) 1997;11(9):1295-300; discussion 1302-10.
1997: R Bhatia; Philip B McGlave; Jeffrey S Miller; S Wissink; W N Lin; Catherine M Verfaillie
A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Experimental hematology 1997;25(9):980-91.
1997: R Bhatia; Catherine M Verfaillie; Jeffrey S Miller; Philip B McGlave
Autologous transplantation therapy for chronic myelogenous leukemia.
Blood 1997;89(8):2623-34.
1997: Jeffrey S Miller; J Tessmer-Tuck; B A Pierson; Daniel Weisdorf; Philip B McGlave; Bruce R Blazar; E Katsanis; Catherine M Verfaillie; J Lebkowski; J Radford; Linda J Burns
Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(1):34-44.
1997: Stella M Davies; John E Wagner; Todd E DeFor; Bruce R Blazar; E Katsanis; John H Kersey; Paul J Orchard; Philip B McGlave; Daniel J Weisdorf; Norma K C Ramsay
Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia.
British journal of haematology 1997;96(4):749-56.
1997: Daniel J Weisdorf; C M Verfaille; Wesley J Miller; Bruce R Blazar; E Perry; X O Shu; K Daniels; P Hannan; Norma K C Ramsay; John H Kersey; Philip B McGlave
Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial.
American journal of hematology 1997;54(3):202-8.
1997: Stella M Davies; John E Wagner; Xiao-Ou Shu; Bruce R Blazar; E Katsanis; Paul J Orchard; John H Kersey; Kathryn E Dusenbery; Daniel J Weisdorf; Philip B McGlave; Norma K C Ramsay
Unrelated donor bone marrow transplantation for children with acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):557-65.
1997: R Bhatia; Philip B McGlave
Autologous stem cell transplantation for the treatment of chronic myelogenous leukemia.
Cancer treatment and research 1997;77():357-74.
1996: Stella M Davies; John E Wagner; Daniel J Weisdorf; X O Shu; Bruce R Blazar; H Enright; Philip B McGlave; Norma K C Ramsay
Unrelated donor bone marrow transplantation for hematological malignancies-current status.
Leukemia & lymphoma 1996;23(3-4):221-6.
1996: K E Dusenbery; Michael Steinbuch; Philip B McGlave; Norma K C Ramsay; Bruce R Blazar; Joseph P Neglia; C Litz; John H Kersey; William G Woods
Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
International journal of radiation oncology, biology, physics 1996;36(2):335-43.
1996: John E Wagner; J Rosenthal; R Sweetman; X O Shu; Stella M Davies; Norma K C Ramsay; Philip B McGlave; L Sender; Mitchell S Cairo
Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.
Blood 1996;88(3):795-802.
1996: H Enright; Stella M Davies; Todd E DeFor; X Shu; Daniel Weisdorf; Wesley J Miller; Norma K C Ramsay; D Arthur; Catherine M Verfaillie; J Miller; J Kersey; Philip B McGlave
Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.
Blood 1996;88(2):714-20.
1996: H Enright; Philip B McGlave
Chronic myelogenous leukemia.
Current opinion in hematology 1996;3(4):303-9.
1996: Philip B McGlave; R Bhatia; C Verfaillie
Cyclophosphamide/GM-CSF priming in autotransplant therapy for CML.
Bone marrow transplantation 1996;17 Suppl 3():S65-6.
1996: H Enright; K Daniels; Diane C Arthur; K E Dusenbery; John H Kersey; T Kim; Wesley J Miller; Norma K C Ramsay; G M Vercellotti; Daniel J Weisdorf; Philip B McGlave
Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome.
Bone marrow transplantation 1996;17(4):537-42.
1996: K Y Chiang; Daniel J Weisdorf; Stella M Davies; H Enright; John H Kersey; Philip B McGlave; Wesley J Miller; Norma K C Ramsay; Michael Steinbuch; John E Wagner; Bruce R Blazar
Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
Bone marrow transplantation 1996;17(1):39-42.
1995: F Cervantes; X O Shu; Philip B McGlave; Norma K C Ramsay; Wesley J Miller; J H Kersey; Daniel J Weisdorf
Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1995;16(3):387-92.
1995: R Bhatia; Philip B McGlave; Catherine M Verfaillie
Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.
The Journal of clinical investigation 1995;96(2):931-9.
1995: Linda J Burns; K A Daniels; Philip B McGlave; Wesley J Miller; Norma K C Ramsay; J H Kersey; Daniel J Weisdorf
Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival.
Bone marrow transplantation 1995;16(1):13-8.
1995: R Bhatia; Philip B McGlave; G W Dewald; Bruce R Blazar; Catherine M Verfaillie
Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
Blood 1995;85(12):3636-45.
1995: Daniel J Weisdorf; Catherine M Verfaillie; Stella M Davies; Alexandra H Filipovich; John E Wagner; Jeffrey S Miller; J Burroughs; Norma K C Ramsay; J H Kersey; Philip B McGlave
Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.
Blood 1995;85(12):3452-6.
1995: R Bhatia; Philip B McGlave
T lymphocytes cultured from chronic myelogenous leukemia bone marrow suppress autologous hematopoietic progenitors.
Leukemia 1995;9(6):1006-12.
1995: E W Greeno; R Haake; Philip B McGlave; Daniel Weisdorf; Catherine M Verfaillie
Lupus inhibitors following bone marrow transplant.
Bone marrow transplantation 1995;15(2):287-91.
1995: K E Dusenbery; K A Daniels; J S McClure; Philip B McGlave; Norma K C Ramsay; Bruce R Blazar; Joseph P Neglia; John H Kersey; William G Woods
Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
International journal of radiation oncology, biology, physics 1995;31(1):119-28.
1994: Jeffrey S Miller; S Klingsporn; J Lund; E H Perry; Catherine M Verfaillie; Philip B McGlave
Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.
Bone marrow transplantation 1994;14(4):555-62.
1994: Catherine M Verfaillie; Allison Hinds; Joji Iida; Philip B McGlave; James B McCarthy
Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor.
Blood 1994;84(6):1802-11.
1994: I M Hings; Richard K Severson; Alexandra H Filipovich; Bruce R Blazar; J H Kersey; Norma K C Ramsay; Philip B McGlave; Daniel J Weisdorf
Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation.
Transplantation 1994;58(4):437-42.
1994: Stella M Davies; Daniel J Weisdorf; R J Haake; John H Kersey; Philip B McGlave; Norma K C Ramsay; Bruce R Blazar
Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14(1):73-7.
1994: R Bhatia; E A Wayner; Philip B McGlave; Catherine M Verfaillie
Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
The Journal of clinical investigation 1994;94(1):384-91.
1994: J S Miller; K A Alley; Philip B McGlave
Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.
Blood 1994;83(9):2594-601.
1994: L A Ochs; Wesley J Miller; Alexandra H Filipovich; R J Haake; Philip B McGlave; Bruce R Blazar; Norma K C Ramsay; J H Kersey; Daniel J Weisdorf
Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
Bone marrow transplantation 1994;13(4):455-60.
1994: Stella M Davies; Norma K C Ramsay; R J Haake; John H Kersey; Daniel J Weisdorf; Philip B McGlave; Bruce R Blazar
Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts.
Bone marrow transplantation 1994;13(1):51-7.
1994: Philip B McGlave; C Verfaillie; J Miller
Interaction of primitive human myeloid and lymphoid progenitors with the marrow microenvironment.
Blood cells 1994;20(1):121-6; discussion 126-8.
1994: Jeffrey S Miller; Catherine M Verfaillie; Philip B McGlave
Expansion and activation of human natural killer cells for autologous therapy.
Journal of hematotherapy 1994;3(1):71-4.
1994: Jeffrey S Miller; Catherine M Verfaillie; Philip B McGlave
Expansion and activation of human natural killer cells as therapy for autologous transplantation.
Progress in clinical and biological research 1994;389():39-45.
1994: Philip B McGlave
Autografting for chronic myelocytic leukemia.
Bone marrow transplantation 1994;14 Suppl 3():S49-50.
1994: H Enright; S Davies; Philip B McGlave
Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
Clinical transplants 1994;():283-93.
1993: Daniel Weisdorf; Alexandra H Filipovich; Philip B McGlave; Norma K C Ramsay; J Kersey; Wesley J Miller; Bruce R Blazar
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
Bone marrow transplantation 1993;12(5):531-6.
1993: K Faber-Langendoen; A L Caplan; Philip B McGlave
Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use.
Bone marrow transplantation 1993;12(5):501-7.
1993: J Kersey; Alexandra H Filipovich; Philip B McGlave; W Woods; Daniel Weisdorf; Joseph P Neglia; K Dusenbery; Bruce R Blazar; M Nesbit; Norma K C Ramsay
Donor and host influences in bone marrow transplantation for immunodeficiency disease and leukemia.
Seminars in hematology 1993;30(4 Suppl 4):105-8; discussion 109.
1993: Philip B McGlave; C Verfaillie; J Miller
Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():10-3.
1993: I M Hings; Alexandra H Filipovich; Wesley J Miller; B L Blazar; Philip B McGlave; Norma K C Ramsay; J H Kersey; Daniel J Weisdorf
Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial.
Transplantation 1993;56(3):577-80.
1993: H Enright; R Haake; Daniel Weisdorf; Norma K C Ramsay; Philip B McGlave; J Kersey; W Thomas; D McKenzie; Wesley J Miller
Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy.
Transplantation 1993;55(6):1339-46.
1993: V A Morrison; Philip B McGlave
Mucormycosis in the BMT population.
Bone marrow transplantation 1993;11(5):383-8.
1993: A S Gamis; R Haake; Philip B McGlave; Norma K C Ramsay
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):834-8.
1992: Jeffrey S Miller; S Oelkers; Catherine M Verfaillie; Philip B McGlave
Role of monocytes in the expansion of human activated natural killer cells.
Blood 1992;80(9):2221-9.
1992: J S Miller; C Verfaillie; Philip B McGlave
The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
Blood 1992;80(9):2182-7.
1992: Catherine M Verfaillie; James B McCarthy; Philip B McGlave
Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
The Journal of clinical investigation 1992;90(4):1232-41.
1992: A H Filipovich; R S Shapiro; N K Ramsay; T Kim; B Blazar; J Kersey; Philip B McGlave
Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
Blood 1992;80(1):270-6.
1992: J Roy; Philip B McGlave; Alexandra H Filipovich; Wesley J Miller; Bruce R Blazar; Norma K C Ramsay; J H Kersey; Daniel J Weisdorf
Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.
Bone marrow transplantation 1992;10(1):77-82.
1992: Catherine M Verfaillie; Wesley J Miller; K Boylan; Philip B McGlave
Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression.
Blood 1992;79(4):1003-10.
1991: D F Stroncek; Philip B McGlave; Norma K C Ramsay; Jeffrey McCullough
Effects on donors of second bone marrow collections.
Transfusion 1991;31(9):819-22.
1991: C Verfaillie; Daniel Weisdorf; R Haake; M Hostetter; Norma K C Ramsay; Philip B McGlave
Candida infections in bone marrow transplant recipients.
Bone marrow transplantation 1991;8(3):177-84.
1991: Daniel J Weisdorf; R Haake; Wesley J Miller; Philip B McGlave; T W LeBien; DA Vallera; L C Lasky; T H Kim; B A Peterson; Norma K C Ramsay
Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.
Bone marrow transplantation 1991;8(2):135-42.
1991: Daniel Weisdorf; R Hakke; Bruce R Blazar; Wesley J Miller; Philip B McGlave; Norma K C Ramsay; J Kersey; Alexandra H Filipovich
Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.
Transplantation 1991;51(6):1197-203.
1991: Jeffrey S Miller; Catherine M Verfaillie; Philip B McGlave
Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors.
Blood 1991;77(11):2389-95.
1991: Catherine M Verfaillie; Philip B McGlave
Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors.
Blood 1991;77(2):263-70.
1990: T H Kim; Philip B McGlave; Norma K C Ramsay; W Woods; Bruce C Bostrom; G Vercellotti; D Hurd; W Krivit; M Nesbit; R Haake
Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission.
International journal of radiation oncology, biology, physics 1990;19(4):889-97.
1990: A H Filipovich; D Vallera; Philip B McGlave; D Polich; K Gajl-Peczalska; R Haake; L Lasky; Bruce R Blazar; Norma K C Ramsay; J Kersey
T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
Transplantation 1990;50(3):410-5.
1990: C Verfaillie; K Blakolmer; Philip B McGlave
Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.
The Journal of experimental medicine 1990;172(2):509-2.
1990: Philip B McGlave; D Arthur; Wesley J Miller; L Lasky; J Kersey
Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
Bone marrow transplantation 1990;6(2):115-20.
1990: Catherine M Verfaillie; N Kay; Wesley J Miller; Philip B McGlave
Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia.
Blood 1990;76(2):401-8.
1990: Philip B McGlave
Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.
Seminars in hematology 1990;27(3 Suppl 4):23-30.
1990: Daniel Weisdorf; R Haake; Bruce R Blazar; Wesley J Miller; Philip B McGlave; Norma K C Ramsay; J Kersey; Alexandra H Filipovich
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.
Blood 1990;75(4):1024-30.
1990: D D Hurd; R J Haake; L C Lasky; Neal Christiansen; Philip B McGlave; Bruce C Bostrom; E G Levine; Daniel J Weisdorf; T H Kim; B A Peterson
Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.
Medical and pediatric oncology 1990;18(6):447-53.
1989: Catherine M Verfaillie; Wesley J Miller; N Kay; Philip B McGlave
Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity.
Blood 1989;74(2):793-7.
1989: Bruce R Blazar; John H Kersey; Philip B McGlave; DA Vallera; L C Lasky; R J Haake; Bruce C Bostrom; D R Weisdorf; C Epstein; Norma K C Ramsay
In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts.
Blood 1989;73(3):849-57.
1989: L C Lasky; N Van Buren; Daniel J Weisdorf; A Filipovich; Philip B McGlave; John H Kersey; Jeffrey McCullough; Norma K C Ramsay; Bruce R Blazar
Successful allogeneic cryopreserved marrow transplantation.
Transfusion 1989;29(2):182-4.
1988: D D Hurd; T W LeBien; L C Lasky; R J Haake; Norma K C Ramsay; T H Kim; E G Levine; Philip B McGlave; C D Bloomfield; B A Peterson
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.
The American journal of medicine 1988;85(6):829-34.
1988: Philip B McGlave; R J Haake; Bruce C Bostrom; R Brunning; D D Hurd; T H Kim; M E Nesbit; Gregory M Vercellotti; Daniel Weisdorf; W G Woods
Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission.
Blood 1988;72(5):1512-7.
1988: Bruce R Blazar; M B Widmer; John H Kersey; Norma K C Ramsay; Philip B McGlave; D L Urdal; S Gillis; C Henney; DA Vallera
Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
Behring Institute Mitteilungen 1988;(83):170-80.
1988: Daniel J Weisdorf; Philip B McGlave; Norma K C Ramsay; Wesley J Miller; M E Nesbit; W G Woods; A I Goldman; T H Kim; J H Kersey
Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children.
British journal of haematology 1988;69(3):351-8.
1988: R S Shapiro; A Chauvenet; W McGuire; A Pearson; A W Craft; Philip B McGlave; A Filipovich
Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.
The New England journal of medicine 1988;318(20):1334.
1987: Philip B McGlave; R Haake; Wesley J Miller; T Kim; J Kersey; Norma K C Ramsay
Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation.
Blood 1987;70(5):1325-30.
1987: Daniel J Weisdorf; M E Nesbit; Norma K C Ramsay; W G Woods; A I Goldman; T H Kim; D D Hurd; Philip B McGlave; J H Kersey
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1348-55.
1987: Philip B McGlave; E Scott; Norma K C Ramsay; D Arthur; Bruce R Blazar; Jeffrey McCullough; J Kersey
Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia.
Blood 1987;70(3):877-81.
1987: A H Filipovich; D A Vallera; R J Youle; R Haake; Bruce R Blazar; D Arthur; D M Neville; Norma K C Ramsay; Philip B McGlave; J H Kersey
Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
Transplantation 1987;44(1):62-9.
1987: Philip B McGlave; D Arthur; R Haake; D Hurd; Wesley J Miller; G Vercellotti; Daniel Weisdorf; T Kim; Norma K C Ramsay; J Kersey
Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1033-40.
1987: S A Weisdorf; J Lysne; D Wind; R J Haake; Harvey Sharp; A Goldman; K Schissel; Philip B McGlave; N K Ramsay; J H Kersey
Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation.
Transplantation 1987;43(6):833-8.
1986: Wesley J Miller; P Flynn; Jeffrey McCullough; H H Balfour; A Goldman; R Haake; Philip B McGlave; Norma K C Ramsay; J Kersey
Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.
Blood 1986;67(4):1162-7.
1985: Norma K C Ramsay; T LeBien; M Nesbit; Philip B McGlave; Daniel Weisdorf; P Kenyon; D Hurd; A Goldman; T Kim; J Kersey
Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement.
Blood 1985;66(3):508-13.
1985: Bruce C Bostrom; R D Brunning; Philip B McGlave; Norma K C Ramsay; M Nesbit; W G Woods; D Hurd; W Krivit; T Kim; A Goldman
Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors.
Blood 1985;65(5):1191-6.
1984: S Weisdorf; C Hofland; Harvey Sharp; K Teasley; K Schissel; Philip B McGlave; Norma K C Ramsay; J Kersey
Total parenteral nutrition in bone marrow transplantation: a clinical evaluation.
Journal of pediatric gastroenterology and nutrition 1984;3(1):95-100.
1983: M O'Leary; N K Ramsay; M E Nesbit; D Hurd; W G Woods; W Krivit; T H Kim; Philip B McGlave; J Kersey
Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. A pilot study.
The American journal of medicine 1983;74(3):497-501.
1982: J H Kersey; N K Ramsay; T Kim; Philip B McGlave; W Krivit; S Levitt; Alexandra H Filipovich; W Woods; M O'Leary; P Coccia; M E Nesbit
Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study.
Blood 1982;60(2):400-3.